We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Test Identifies Aspirin Resistance in Heart Patients

By HospiMedica staff writers
Posted on 28 Mar 2001
A new diagnostic test identifies heart patients who are nonresponsive to aspirin, so doctors can prescribe alternate anti-platelet drugs.

Recent studies have reported that up to 15-20% of all heart patients currently taking aspirin as a preventive tool do not respond appropriately to aspirin's ability to reduce platelet function or they have become resistant to aspirin over time. More...
The new assay enables doctors to detect and monitor a heart patient's response to aspirin when used for the prevention of heart attacks and strokes. The test could also be used to determine compliance in patients on an aspirin regimen.

The test, called Aspirincheck, requires only a urine sample and provides results in two days. It was developed by Esoterix Coagulation (Aurora, CO, USA), which provides technology-based laboratory services and information.

"Tradition dictates that we test to monitor the effectiveness of long-term medication such as lipid-lowering drugs, so it makes sense that we start testing to monitor aspirin's effectiveness as well,” said Alexander Duncan, M.D., of Emory University (Atlanta, GA, USA).



Related Links:
Esoterix Coagulation

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.